OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Altman said that a project like Stargate might not have been possible with "a different president." ...
Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.
We recently published a list of 10 AI Stocks Investors are Watching Closely. In this article, we are going to take a look at ...
The announcement confirms one of two rumors that circled the internet this week. The other was about superintelligence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback